References
- Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157–160.
- Robinot R, Hubert M, de Melo GD, et al. SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance. Nat Commun. 2021;12(1):4354.
- Cai J, Sun W, Huang J, et al. Indirect virus transmission in cluster of COVID-19 cases, wenzhou, China, 2020. Emerg Infect Dis. 2020;26(6):1343–1345.
- Spassky N, Meunier A. The development and functions of multiciliated epithelia. Nat Rev Mol Cell Biol. 2017;18(7):423–436.
- Chatterjee M, van Putten JPM, Strijbis K. Defensive properties of mucin glycoproteins during respiratory infections-relevance for SARS-CoV-2. mBio. 2020;11(6): e02374–20.
- Jones N. The nose and paranasal sinuses physiology and anatomy. Adv Drug Deliv Rev. 2001;51(1–3):5–19.
- Cecen A, Bayraktar C, Ozgur A, et al. Evaluation of nasal mucociliary clearance time in COVID-19 patients. J Craniofac Surg. 2021;32(8):e702–e705.
- Kahraman ME, Yüksel F, Özbuğday Y. The relationship between covid-19 and mucociliary clearance. Acta Otolaryngol. 2021;141(11):989–993.
- Koparal M, Kurt E, Altuntas EE, et al. Assessment of mucociliary clearance as an indicator of nasal function in patients with COVID-19: a cross-sectional study. Eur Arch Otorhinolaryngol. 2021;278(6):1863–1868.
- Ugurlu B, Yerlikaya H, Ugurlu G, et al. Evaluation of nasal mucociliary clearance in COVID-19 patients. KBB ve BBC Dergisi. 2021;29(2):95–99.
- Greenstone M, Cole PJ. Ciliary function in health and disease. Br J Dis Chest. 1985;79(1):9–26.
- Alho OP. Nasal airflow, mucociliary clearance, and sinus functioning during viral colds: effects of allergic rhinitis and susceptibility to recurrent sinusitis. Am J Rhinol. 2004;18(6):349–355.
- Xavier RF, Ramos D, Ito JT, et al. Effects of cigarette smoking intensity on the mucociliary clearance of active smokers. Respiration. 2013;86(6):479–485.
- Kao CH, Jiang RS, Wang SJ, et al. Influence of age, gender, and ethnicity on nasal mucociliary clearance function. Clin Nucl Med. 1994;19(9):813–816.
- Sungnak W, Huang N, Becavin C; HCA Lung Biological Network, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26(5):681–687.
- Hui KPY, Cheung MC, Perera R, et al. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Respir Med. 2020;8(7):687–695.
- Janssen WJ, Stefanski AL, Bochner BS, et al. Control of lung defence by mucins and macrophages: ancient defence mechanisms with modern functions. Eur Respir J. 2016;48(4):1201–1214.
- Pizzorno A, Padey B, Julien T, et al. Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia. Cell Rep Med. 2020;1(4):100059.
- Agyeman AA, Chin KL, Landersdorfer CB, et al. Smell and taste dysfunction in patients with COVID-19: a systematic review and Meta-analysis. Mayo Clin Proc. 2020;95(8):1621–1631.
- Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease-2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–690.